- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06483087
Effect of Animated Education on Anxiety and Vascular Complications (VAEdA)
The Effect of Animated Education Program on Anxiety, Vascular Complications, And Flat Time Among Children Undergoing Cardiac Catheterization
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
After ethical approvals are obtained, to facilitate the process of data collection, the researcher will contact the director of nursing and the head nurse of the pediatric cardiac clinic to inform them about the purpose, protocol, and duration of data collection. All days of the week, excluding holidays and weekends, between the hours of seven AM and four PM, recruitment, intervention, and data collecting will take place. To identify the clinical data regarding the health status of the children who will participate, the researcher will review children's medical records and contact their cardiologists. The researcher will introduce herself to the study participants, a simple explanation of the study's aims without mentioning anxiety level specifically, and the method of data collection will be clarified to gain their approval to participate in the study. Data collection for this study will be carried out for three months. Every child with parents will be interviewed individually by the researcher to collect the necessary data, and the interview will be conducted within 20 minutes. The interview will be classified into four phases (assessment phase, planning phase, implementation phase, and evaluation phase).
Assessment phase In QACHD, the schedule for the CC procedure is informed at 2 pm on the day before CC, when it is confirmed, which children will undergo CC the next day, the following steps will be followed; The researcher will approach the children and parents in the children's rooms and provide them with a description of the study phases. Children who expressed interest in participating in the study and are eligible to participate, researchers will ask their parents to sign the consent form, and the children's assent will also be obtained. The researcher will collect the baseline sociodemographic questionnaire from both study groups (Tool 1). Then randomize study groups for control and intervention as mentioned before.
Implementation phase Usual care will be presented to both study groups by the health team members in the pediatric unit. The researcher will present an animated education program individually to the children in the intervention group 24 hours before undergoing CC. To reduce interruptions during a teaching session and data collecting, a sign stating "Study in progress please do not disrupt" will be posted on the front door of the children's room. The AEP will be loaded on a laptop. The program will be presented in 12 minutes. The animated education program will familiarize children and their parents with the events occurring before, during, and after the post-CC procedure. Children's acquisition of the knowledge and skills taught in the AEP will be evaluated by using the ten-minute discussion that will be offered after they receive intervention from the researcher. Children in the intervention group will be encouraged to ask questions related to the material presented in the AEP. All answers to participants' questions will be provided based on the material available in the literature so that the same questions will be answered in the same way.
Evaluation phase:
After giving standardized instructions to respond to the SASC presented to children, children will be asked to read and answer the Arabic version of the SASC. Children will be informed to ask the researcher's assistance (data collector) to read the tool for them if they find difficulties in reading. Children's anxiety level will be assessed 2 hours before undergoing CC; based on previous literature findings CC-related anxiety is highest on the day of the procedure just before the CC procedure. Vascular complications will be assessed 2 hours post sheath removal by trained staff nurses in the pediatric ward; if vascular complications are present will be confirmed by an expert nurse who works in the CC lab. Flat time will be assessed and will be recorded after admission to the recovery area until physician discharge orders are obtained.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jafar Alshraideh, PhD
- Phone Number: 23129 +96277748455665355000
- Email: jalasad@ju.edu.jo
Study Contact Backup
- Name: Nibras Haddad, PhD
- Email: NBR9210034@ju.edu.jo
Study Locations
-
-
-
Amman, Jordan, 11111
- Recruiting
- Jorrdania royalmedical services
-
Contact:
- Jafar Alshraideh
- Phone Number: 23129 +96265355000
- Email: jalasad@ju.edu.jo
-
Contact:
- Email: jalasad@ju.edu.jo
-
Principal Investigator:
- Jafar Alshraideh, PhD
-
Sub-Investigator:
- Nibras Haddad, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- aged between 6-12 years
- admitted for their first scheduled cardiac catheterization non-emergency CC procedure.
Exclusion Criteria:
- children with developmental delay
- emergency CC because
- having major hearing or visual difficulties
- children have deteriorated health conditions before CC and need to be admitted for intensive care before undergoing CC
- children who have bleeding disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: the intervention group
[*]Arm Description: The Animated Education Program (AEP) and usual care interventions provided for children randomly assigned to the experimental group during the day before receiving a CC procedure.
The Animated Education Program (AEP) was developed to prepare children for cardiac catheterization (CC) by improving their knowledge of CC procedures and helping them become familiar with such procedures in all phases.
It will be presented as an AEP for eight minutes; it was uploaded on the researcher's laptop and was presented individually to children in their rooms.
|
Eight minutes animated vedio; presented individually to children in their rooms.
The vedio explains specific aspectsof the cardiac cathetrization procedure.
Other Names:
|
|
No Intervention: Control group
Provide brief procedural instructions, such as time for fasting, and the need to increase the fluid intake post cardiac catheterization.
However, no written or animated materials are used to provide health education for children before undergoing the CC procedure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety
Time Frame: Baseline, Day 1
|
The children's anxiety level will be measured 2 hours before undergoing CC.
Anxiety is an Emotional state consisting of tension feelings, apprehension, nervousness, and worry, with activation or arousal of the autonomic nervous system.
State anxiety is a temporary emotional state reflective of one's interpretation of a particular stressful situation.
The State-Trait Anxiety Inventory for Children consists of twenty statements asking children how they feel at a particular moment.
A 10-item short form of the tool in 2005 that will be used to assess children's state anxiety levels.
The children's anxiety level will be measured 2 hours before undergoing CC.
|
Baseline, Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bleeding at the cardiac catheterization site
Time Frame: Day 1, Day 2, Day 3
|
It is caused by blood leaking from damaged blood vessels from the cardiovascular system. Bleeding may occur through skin puncture at the CC site. Blood oozing through skin puncture, around the catheter insertion site after sheath removal, will be assessed 2 hours after sheath removal, (will be assessed by inspection and palpation if present or not). It will be recorded on a sheet that the researcher will develop. Grade 0 (no bleeding) Grade I (little bleeding at the puncture site) Grade II (Severe bleeding). |
Day 1, Day 2, Day 3
|
|
Hematoma at the cardiac catheterization site
Time Frame: Day1
|
Blood stasis outside of a blood vessel.
It happens when blood leaks into the surrounding tissue through a broken artery, vein, or capillary wall.
Blood collects under the skin around the catheter insertion site after sheath removal, (will be assessed by inspection and palpation if present or not).
The swelling surrounding the puncture site is hard, palpable, and tender (Small hematoma: < 5 cm in diameter, large hematoma: > 5 cm in diameter).
|
Day1
|
|
Flat time
Time Frame: Day 1
|
The amount of time that patients are required to lie flat and restrict their movements for an extended period to prevent vascular complications after cardiac catheterization. The hours that the child stays in a flat position in bed post-sheath removal will be recorded on the sheet that the researcher will develop. Will be recorded after admission to the recovery area until physician discharge orders are obtained. It will be measured in hours as follows: < 4 Hours 4 to <6 Hours 6-8 Hours |
Day 1
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 101271-6
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Catheterization
-
Lawson Health Research InstituteCompletedCardiac CatheterizationCanada
-
Ramsay Générale de SantéEuropean Clinical Trial Experts NetworkRecruitingCardiac MRI | Right Cardiac CatheterizationFrance
-
Mansoura UniversityCompletedCardiac CatheterizationEgypt
-
Duke UniversityCAS Medical Systems, Inc.Terminated
-
RWTH Aachen UniversityWithdrawnCardiac CatheterizationGermany
-
Brigham and Women's HospitalAbbott Medical DevicesUnknownCardiac CatheterizationUnited States
-
Assiut UniversityNot yet recruiting
-
Blackpool Victoria HospitalUnknownFasting | Cardiac CatheterizationUnited Kingdom
-
National Children's Hospital, VietnamRecruitingCardiac Catheterization | PediatricVietnam
-
John R. CharpieRecruitingCardiac Catheterization | Endotracheal TubeUnited States
Clinical Trials on Animated Education Program
-
T.C. ORDU ÜNİVERSİTESİNot yet recruitingMenstruation | Education | Student | Animation
-
Trakya UniversityNot yet recruiting
-
Oslo University HospitalUniversity of Oslo; University of Birmingham; Croydon University Hospital; Birzeit...CompletedComplication of Labor and DeliveryPalestinian Territory, occupied
-
Eugen FeistCompleted
-
Jubilee Mission Medical College and Research InstituteCompleted
-
Direction Centrale du Service de Santé des ArméesNot yet recruitingProstate CancerFrance, Guadeloupe
-
IWK Health CentreRecruitingPaediatric Surgery | Pre-operative Anxiety | OtoplastyCanada
-
University of California, San FranciscoRecruitingDiabetic Retinopathy (DR) | Macular Edema (ME)United States
-
University Hospital FreiburgStanford University; Heidelberg UniversityNot yet recruitingPsychological Capital
-
Near East University, TurkeyCompletedType 1 Diabetes MellitusTurkey